NCT05953337 2026-03-04
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)
ABK Biomedical
Phase NA Active not recruiting
ABK Biomedical
Boston Scientific Corporation
Angiodynamics, Inc.
ABK Biomedical